Phibro Animal Health Corp
NASDAQ:PAHC
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| US |
|
Phibro Animal Health Corp
NASDAQ:PAHC
|
2B USD |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
930.7B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
581.6B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
256.9B CHF |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
233.7B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
222.2B GBP |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
286.1B USD |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
151.1B USD |
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
118.9B USD |
Loading...
|
Market Distribution
| Min | -4 087 900% |
| 30th Percentile | -5.1% |
| Median | 6% |
| 70th Percentile | 14.8% |
| Max | 1 032 600% |
Other Profitability Ratios
Phibro Animal Health Corp
Glance View
Phibro Animal Health Corp. engages in the manufacture and supply of animal health and mineral nutrition products. The company is headquartered in Teaneck, New Jersey and currently employs 1,725 full-time employees. The company went IPO on 2014-04-11. The firm operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The firm develops, manufactures and markets a range of products for food animals, including poultry, swine, beef and dairy cattle, and aquaculture. The firm sells animal health and mineral nutrition products either directly to integrated poultry, swine and cattle producers or through commercial animal feed manufacturers, wholesalers and distributors. Its Medicated Feed Additives (MFAs) and other business consist of concentrated medicated products, which are administered through animal feeds. The firm's MFAs and other business consists of the production and sale of antibacterials, including Stafac, Terramycin, Neo-Terramycin and Mecadox and anticoccidials, including Nicarb, Aviax, Aviax Plus, Coxistac and amprolium.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Phibro Animal Health Corp is 12.8%, which is above its 3-year median of 8.7%.
Over the last 3 years, Phibro Animal Health Corp’s Operating Margin has increased from 7.4% to 12.8%. During this period, it reached a low of 5.9% on Sep 30, 2023 and a high of 12.8% on Jan 31, 2026.
